Cytokinetics Inc (CYTK)

Add to Watchlists
Create an Alert
Quickflows
39.03 -1.87  -4.57% NASDAQ Nov 26, 16:00 USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All CYTK News

News

View All Events

Events

Date Type Description
02/25/2022 Earnings Results Q4 2021 Earnings Results
02/25/2022 16:30 EST Earnings Calls Q4 2021 Earnings Call
11/03/2021 Earnings Results Q3 2021 Earnings Results
11/03/2021 16:30 EST Earnings Calls Q3 2021 Earnings Call
08/05/2021 Earnings Results Q2 2021 Earnings Results
08/05/2021 16:30 EST Earnings Calls Q2 2021 Earnings Call
05/12/2021 10:30 EST AGM 2020 Annual General Meeting
05/06/2021 Earnings Results Q1 2021 Earnings Results
05/06/2021 16:30 EST Earnings Calls Q1 2021 Earnings Call
02/25/2021 Earnings Results Q4 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 21.55M
Total Expenses (TTM) 222.57M
Net Income (TTM) -228.67M

Balance Sheet View Statement

Total Assets (Quarterly) 827.54M
Total Liabilities (Quarterly) 578.52M
Shareholders Equity (Quarterly) 249.02M

Cash Flow Statement View Statement

Cash from Operations (TTM) -45.64M
Cash from Investing (TTM) -368.73M
Cash from Financing (TTM) 304.12M

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The treatment is based on small molecules specifically engineered to increase muscle function and contractility.
  • URL: http://www.cytokinetics.com
  • Investor Relations URL: https://ir.cytokinetics.com
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Feb. 25, 2022
  • Last Earnings Release: Nov. 03, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 39.03
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
DEVDX Driehaus Event Driven 2.90%
PSCH Invesco S&P SmallCap Health Care ETF 2.62%
FIJYX Fidelity Advisor® Biotechnology Z 2.31%
SBIO ALPS Medical Breakthroughs ETF 2.11%
DMCRX Driehaus Micro Cap Growth 1.84%
MSSVX AMG Frontier Small Cap Growth N 1.73%
DVSMX Driehaus Small Cap Growth Investor 1.39%
BBC Virtus LifeSci Biotech Clinical Trls ETF 1.18%
XBI SPDR® S&P Biotech ETF 1.12%
FBIOX Fidelity® Select Biotechnology 1.09%
LABU Direxion Daily S&P Biotech Bull 3X ETF 0.84%
HART IQ Healthy Hearts ETF 0.61%

Comparables

Edit
OSMT Osmotica Pharmaceuticals PLC
RXRX Recursion Pharmaceuticals Inc
TLRY Tilray Inc
NBY NovaBay Pharmaceuticals Inc
PTN Palatin Technologies Inc

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.